Pancreatitis, Autoimmune
BackgroundDiagnosisTestsRefs
Clinical Background

Autoimmune pancreatitis (AIP) is a form of chronic pancreatitis characterized by a diffuse enlargement of the pancreas, narrowing of the pancreatic duct, lymphoplasmacytic infiltration and fibrosis, increased serum IgG4 and response to steroid treatment.

Epidemiology

  • Incidence - rare, 5-6% of patients with chronic pancreatitis
  • Age - most are >50 years at onset
  • Gender - More prevalent in males than females

Pathophysiology

  • Histologic hallmark is collar-like preductal infiltrates composed of lymphocytes and plasma cells termed lymphoplasmacytic sclerosing pancreatitis (LPSP)
    • Other organs may be involved including the gallbladder, bile ducts, kidney, lung and salivary glands
    • IgG4 positive plasma cells have been identified in some patients

Clinical Presentation

  • AIP may coexist in about 40-60% of patients with autoimmune diseases such as Sjögren’s syndrome, primary sclerosing cholangitis (PSC) and primary biliary cirrhosis (PBC), suggesting that common targets in the pancreas or exocrine organs such as the salivary gland or biliary tract may be involved in disease pathogenesis
  • Pancreatic
    • Obstructive jaundice
    • Abdominal pain
    • Diabetes
    • Weight loss
  • Extrapancreatic
    • Pulmonary - discrete nodules, diffuse infiltrate, hilar adenopathy
    • Renal - lesions, mild renal insufficiency

Treatment

  • Steroids
    • Positive response to steroids confirms diagnosis
See Also
  Pancreatic Cancer

BackgroundDiagnosisTestsRefs

Provide feedback on this topic